TP53 and neoplasm: Growth inhibition by Nutlin-3/RG7388 was investigated using the sulforhodamine-B (SRB) assay for a panel of wild-type and mutant TP53 ovarian cancer cell lines derived from tumours of different histological subtypes [13–16] (Figure 1A and Table 1).